Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

November 17-18, 2017

New York, New York

Continuing Education

ACCMEPhysicians
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex®, LLC designates this live educational activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.


Maintenance of Certification
ABIM MOC Successful completion of this CME activity enables a participant to earn up to 12.25 MOC points towards the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is Imedex's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.

Who Should Attend
These educational activities are designed to meet the educational needs of medical and radiation oncologists, thoracic surgeons, nurses, diagnostic radiologists, pathologists, pulmonologists, researchers, and other healthcare professionals interested in the care and treatment of patients with thoracic malignancies.

Objectives
Upon successful completion of these educational activities, participants should be better able to:

  • Evaluate new approaches to lung cancer screening and smoking cessation
  • Describe the rationale, benefits, and limitations of emerging diagnostic and prognostic strategies, including liquid biopsies and novel imaging techniques
  • Determine the clinical relevance of emerging data from trials evaluating targeted therapies and immunotherapy for advanced EGFR+ NSCLC
  • Evaluate progress being made in targeting less common markers, such as HER2, BRAF, KRAS, MET, TRK, and RET in lung cancer management
  • Develop a strategy for individualized management of patients with EGFR+ lung cancer
  • Identify best practices in providing patient education and managing treatment expectations with patients with thoracic malignancies